Cited by 1,447Dementia and Cognitive Impairment ResearchCancer-related cognitive impairment studiesAlzheimer's disease research and treatments

Mild Cognitive Impairment: Ten Years Later

Open access
Petersen, Ronald C., Roberts, Rosebud O., Knopman, David S., Boeve, Bradley F., Geda, Yonas E., Ivnik, Robert J., Smith, Glenn E., Jack, Clifford R.·2009·Archives of Neurology

Abstract

In the past 10 years, there has been a virtual explosion in the literature concerning the construct of mild cognitive impairment. The interest in this topic demonstrates the increasing emphasis on the identification of the earliest features of cognitive disorders such as Alzheimer disease and other dementias. Mild cognitive impairment represents the earliest clinical features of these conditions and, hence, has become a focus of clinical, epidemiologic, neuroimaging, biomarker, neuropathological, disease mechanism, and clinical trials research. This review summarizes the progress that has been made while also recognizing the challenges that remain.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/archneurol.2009.266

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Any interval between last clinical evaluation and autopsy creates a potential for misclassification, especially since progression to dementia typically seems to be preceded by a prodrome.

    “Any interval between last clinical evaluation and autopsy creates a potential for misclassification, especially since progression to dementia typically seems to be preceded by a prodrome.33”

    From Ecology of the Aging Human Brain (2011) · cites this paper as [33]

    The History section describes mild cognitive impairment as a prodromal condition distinct from dementia, supporting the point that dementia can be preceded by a prodrome. The Neuropathological Analysis section discusses clinical classifications and findings after death, but does not say that any interval between the last clinical evaluation and autopsy creates a risk of misclassification. No page numbers are available in our copy. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Mild neurocognitive disorder is new to DSM nomenclature, was previously included under cognitive disorder not otherwise specified, and provides a new framework for the commonly used diagnosis of MCI.

    “Mild neurocognitive disorder is a new addition to the DSM nomenclature, previously subsumed by the nonspecific category of 'cognitive disorder not otherwise specified, ' and represents a new framework for the commonly used diagnosis of MCI. 12”

    From Classifying neurocognitive disorders: the DSM-5 approach (2014) · cites this paper as [12]

  • The Mayo Criteria correspond most closely to amnestic MCI in the IWG Criteria, and their main diagnostic objective is to identify Alzheimer disease at the predementia stage.

    “The Mayo Criteria correspond best to what is referred to as amnestic MCI in the IWG Criteria, with the main objective of the diagnosis being the identification of AD at the predementia stage.12”

    From Classifying neurocognitive disorders: the DSM-5 approach (2014) · cites this paper as [12]

  • These memory changes related to higher or increased social isolation are similar to the rates (12%-30% decline in 2 years) found among older people with progressive memory decline and mild cognitive impairment prior to dementia, compared with 2%-4% biannual decline in normal aging.

    “These memory changes related to higher or increased social isolation are similar to the rates (12%–30% decline in 2 years) found among older people with progressive memory decline (Cloutier, Chertkow, Kergoat, Gauthier, & Belleville, 2015) and mild cognitive impairment (Petersen et al., 2009) prior to dementia, compared with 2%–4% biannual decline in normal aging.”

    From Social isolation and memory decline in later-life (2020) · cites this paper as Petersen et al., 2009

  • Amnestic mild cognitive impairment is considered a high risk group for dementia and has become a common target for secondary prevention.

    “Thus, AMCI is considered a high risk group for dementia [6] and has become a common target for secondary prevention.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [4]Petersen RC Petersen RC Conceptual Overview Mild Cognitive Impairment: Aging to Alzheimer’s Disease New York Oxford University Press, Inc 2003 1 14
  2. [27]Roberts R Geda Y Knopman D Men are More Likely to Have Mild Cognitive Impairment Than Women: The Mayo Clinic Study of Aging Neurology 2008 abstract (In press)

Cited by

Sorted by citations

Authors
Petersen, R. C., Roberts, R. O., Knopman, D. S., Boeve, B. F., Geda, Y. E., Ivnik, R. J., Smith, G. E., & Jack, C. R.
Affiliations
Mayo Clinic (US)
Venue
Archives of Neurology
Published
2009-12-01
Volume
66
Issue
12
Pages
1447-55
ISSN
0003-9942 (ISSN-L)
OpenAlex
W1972982304
Cited by
1,447
References
59
Citations by year
2026: 54 · 2025: 74 · 2024: 71 · 2023: 72 · 2022: 93 · 2021: 116 · 2020: 85 · 2019: 89 · 2018: 96 · 2017: 72 · 2016: 98 · 2015: 104 · 2014: 89 · 2013: 102 · 2012: 97
FWCI
46.65
Type
journal article
Language
en
Open access
Locations
  • Archives of Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (5u01ag024904-10)
  • National Institute on Aging (U01-AG-024904, R01AG11378, P50‐AG16574, U01AG06786, U01AG006786, R01AG011378, U19AG010483, P50AG016574)
  • National Institute of Mental Health (K01-MH68351, K01MH068351)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
mild cognitive impairment, Alzheimer's disease, dementia, biomarkers, neuroimaging, neuropathology, disease mechanisms, clinical trials
MeSH terms
Alzheimer Disease, Clinical Trials as Topic, Cognition Disorders, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review